Media Releases › Arovella Therapeutics

SUDA Pharmaceuticals Limited (ASX:SUD), a leader in oro-mucosal drug delivery, released its Appendix 4C for the consolidated Group for the first quarter of FY 2020. 

For more information, download the attached PDF.  Download this document